Takeover
Commented by Fabian Lorenz on October 7th, 2026 | 08:50 CEST
Takeover Battle Intensifies: BASF, Evonik, Gerresheimer and Phenom Resources
The takeover battle surrounding BASF and Evonik is intensifying, and politicians are now getting involved as well. The state government is demanding job guarantees, while the leader of the SPD parliamentary group in North Rhine-Westphalia has voiced criticism and called on Minister President Hendrik Wüst to step up his efforts and provide greater clarity. Phenom Resources is a hot stock with takeover potential. The Canadian company is focused on gold and vanadium projects in the US state of Nevada. Its gold and copper assets are set to be spun off—but could a strategic partner make a move instead? Gerresheimer was already in the crosshairs of financial investors back in 2025. Since the failed takeover attempt, however, things have been relatively quiet. The company is currently restructuring and streamlining its business. That could eventually put it back on potential buyers' radar.
Read
Commented by Fabian Lorenz on September 17th, 2026 | 07:15 CEST
Gold at USD 10,000? Desert Gold Poised for Gold Production, Takeover Speculation and Multi-Bagger Potential
Is this gold stock about to take off? The gold price currently seems unable to decide which direction to take. On the one hand, interest-rate concerns loom; on the other, steadily rising government debt worldwide points to further price gains. Experts, in any case, remain bullish. State Street and Saxo Bank even consider a gold price of USD 10,000 per troy ounce possible in the coming years. Regardless, there are good reasons why Desert Gold stock could break out of its sideways trend to the upside in the coming weeks. The company is targeting the start of gold production in the fourth quarter. Production costs are estimated at USD 1,100 per ounce. This could fuel takeover speculation. Analysts see multi-bagger potential in the stock.
Read
Commented by André Will-Laudien on September 8th, 2026 | 09:40 CEST
Biotech: Time to Bet on the Rebound! Evotec and BioNxt in the Takeover Spotlight, Bayer and BioNTech Flush with Cash
After a long dry spell, the biotech sector is on the cusp of a spectacular turnaround, offering bold investors the potential for significant returns. Many innovative biotech stocks are trading well below their all-time highs, yet almost unnoticed, the next major rally is already taking shape behind the scenes. The huge cash reserves of industry giants Bayer and BioNTech are currently fueling takeover speculation across the sector. This colossal capital, running into the billions, is desperately seeking new growth drivers, suddenly putting smaller players on the radar of potential acquirers. At the very top of the hunters' watchlist are the hard-hit Evotec and the disruptive newcomer BioNxt. Both companies boast top-class technology platforms, which, at current levels, almost seem like an exclusive clearance sale. Investors who keep their eyes open and position themselves strategically for the major rebound could get ahead of the looming wave of consolidation. The conditions for an explosive catch-up rally have rarely been this favorable.
Read
Commented by Stefan Bode on August 5th, 2026 | 07:25 CEST
Between All-Time Highs and M&A Fever: Adidas, Commerzbank, Desert Gold, and Unicredit in Focus
This week's stock market action, with indices hitting new all-time highs, also presents investors with a mix of operational transformations, M&A speculation, and opportunities to capitalize on temporary price volatility. In the consumer goods sector, short-term margin concerns are leading to drastic sell-offs despite strong record sales, while commodity stocks are benefiting from robust international demand. At the same time, the banking sector is coming into focus due to record profits and an intensifying takeover battle in Germany. Read here to find out which three highly exciting investment stories are likely to be driving market participants right now.
Read
Commented by André Will-Laudien on July 29th, 2026 | 07:50 CEST
Active Ingredients, Acquisitions and Spin-offs: Will Bayer, Novo Nordisk, BioNxt, or Evotec Become Top M&A Targets?
After years of consolidation, investors are asking: Will things start looking up again? The global life sciences sector is facing another massive wave of consolidation in 2026 as established pharmaceutical giants and agile biotech pioneers realign their businesses. Market dynamics remain high, but unfortunately, both sides are being exploited. So far, it has been predominantly speculative investors who are capitalizing on the current volatility. Following drastic share price losses and ongoing restructuring, the struggling Hamburg-based biotech company Evotec is increasingly in the crosshairs of financially strong acquirers seeking to acquire high-calibre drug discovery platforms at a bargain price. At the same time, BioNxt is attracting investor interest with its groundbreaking drug delivery systems and advanced clinical pipelines. Meanwhile, the market continues to speculate feverishly about a possible breakup or spin-off of individual divisions at the DAX-listed Bayer Group, which would massively increase its appeal to strategic buyers. On the other hand, Danish industry leader Novo Nordisk, driven by the sustained billion-dollar profits from its weight-loss portfolio, is acting as a financially powerful hunter in search of strategic acquisitions in the obesity and cardiovascular segments. For investors, this highly dynamic environment offers a rare opportunity to bet early on the year's hottest takeover candidates. What is the current status?
Read
Commented by Carsten Mainitz on June 4th, 2026 | 07:45 CEST
Takeover Fever! BioNxt Solutions, Delivery Hero, and Commerzbank in the Spotlight: How Investors Can Benefit!
The entry of a strategic investor or the prospect of a takeover regularly leads to significant price surges and even massive revaluations. The momentum is enormous; the global market for mergers and acquisitions has reached new records. Especially during periods of technological upheaval, geopolitical realignment, and increasing competitive pressure, companies are increasingly turning to acquisitions to secure growth, resources, or market share. In this context, there are exciting and lucrative developments for investors at BioNxt Solutions, Delivery Hero, and Commerzbank. The investment case for BioNxt Solutions is particularly compelling. The Canadian company aims to bring an alternative to weight-loss injections to market. If successful, this could create a billion-dollar business and attract acquirers. How should investors position themselves?
Read
Commented by Tarik Dede on April 24th, 2026 | 07:15 CEST
Is Agnico Eagle sparking a wave of takeovers? K92 Mining and DRC Gold in the spotlight!
Agnico Eagle has acquired three projects in Finland and is establishing a second hub there alongside its operations in Québec. The world's second-largest gold producer is making headlines primarily with its CAD 2.9 billion acquisition of Rupert Resources. The Canadians aim to challenge Newmont with this move. K92 Mining could become the next target of a takeover wave due to its success in Papua New Guinea, as the company is performing exceptionally well operationally. DRC Gold in the Democratic Republic of the Congo, meanwhile, could emerge as a potential acquisition target in Africa. The company is already on track to develop two gold mines simultaneously.
Read
Commented by Nico Popp on April 10th, 2026 | 07:15 CEST
Gold Renaissance in Nevada: Nevada Gold Mines, Kinross Gold, and Takeover Candidate Lahontan Gold
Gold has shown increased volatility in recent weeks, while geopolitical developments continue to shape capital allocation across the sector. In response, producers are increasingly focusing on politically stable regions where existing infrastructure offers cost advantages. According to the Fraser Institute, Nevada remains one of the most attractive regions globally for mining investment. While industry leaders such as Nevada Gold Mines are setting standards through optimizations at their large-scale mines and corporations like Kinross Gold are actively searching for new resources in the Walker-Lane trend to replace their dwindling reserves, junior explorers offer a unique opportunity. The up-and-coming company Lahontan Gold operates the Santa Fe project, a former producing mine that recently made headlines with strong drill results. Thanks to a combination of existing permits and its location in one of the world's most productive gold regions, the company's flagship project aligns closely with the acquisition criteria of larger producers.
Read
Commented by Fabian Lorenz on March 12th, 2026 | 07:25 CET
Breaking News! Takeover speculation? BioNTech, Evotec, Vidac Pharma
First, the positive news: Vidac Pharma's drug candidate VDA-1102 was recently used in a compassionate treatment case in connection with a girl's third brain surgery. Following the treatment, the patient's condition improved significantly. In addition, the Vidac platform is now being tested beyond oncology. 2026 could mark a potential breakthrough year for the company and its stock. It was a different story this week for BioNTech, whose shares suffered a sharp setback. The rather mixed results for 2025 and the cautious outlook for the current year likely played only a limited role. More troubling for shareholders is likely the impending departure of the founding couple. This raises the question: Could BioNTech become a takeover target? There were also long faces at Evotec this week. The company's restructuring program has failed to convince the market, and the stock has slipped below an important technical support level.
Read
Commented by Fabian Lorenz on March 4th, 2026 | 07:15 CET
Over 100% upside potential and takeover speculation! Could raw materials gem Power Metallic Mines follow in the footsteps of Norilsk Nickel?
Norilsk Nickel (Nornickel) is regarded as the benchmark for multi-metal projects in the global mining industry. Anyone aiming to approach the scale of this mining giant sets highly ambitious goals. This is precisely the case with Power Metallic Mines. The company reaffirmed this positioning at a recent investor conference. Its latest drilling results were once again spectacular, indicating that something big may be taking shape. Power Metallic Mines controls a world-class multi-metal deposit containing copper, platinum, palladium, cobalt, gold, and silver. Analysts are enthusiastic and see upside potential of more than 100%. They are also fueling speculation about a possible takeover.
Read